Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?
TheFly reported on June 29 that Leerink Partners characterized the FDA’s premarket approval of LungFX for UTHR as a positive development for the company and the broader transplantation sector.






